About Genexis Biotech
Genexis Biotech is a Healthcare company based in Vadodara (India) founded in 2019 by Jitendra Wagh and Vipul Kumar. It operates as a services in microbiology, molecular biology, and microbial fermentation are provided. Genexis Biotech has raised $611.34 thousand across 3 funding rounds from investors including Gujarat Venture Finance, Indigram Labs and Benzai10 Investment Ventures. Genexis Biotech was last valued at $2.74 million in October 2024. Its Indian entity Genexis Biotech Private Limited reported revenue of ₹32.9 Lakh. Genexis Biotech offers products and services including FBS Alternative, Growth Factors, Animal Origin-Free Proteins, and Cell Culture Media. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Reagents and Kits and Diversified. Its competitors include Abcam, Stem Cell Technologies, Meridian Bioscience, Teknova and Sangon Biotech and 4 more; 5 of its 9 listed competitors have raised funding.
Company details
Genexis Biotech was established in 2019 in Vadodara, India, within the biotechnology sector. Full-spectrum services in microbiology, molecular biology, and microbial fermentation solutions are delivered. Precision fermentation and cell culture-based technologies are employed to create alternative proteins via biological platforms. Operations focus on addressing biotechnology requirements through these methods.
- Headquarters Vadodara, India
- Founders Jitendra Wagh, Vipul Kumar
- Stage Minicorn
- SectorsHealthcare
- Email••••••••
- Website genexisbiotech.com
- Social LinkedIn X
- Legal Name Genexis Biotech Private Limited
- Date of Incorporation 14 Oct, 2019
- Jurisdiction Vadodara, Gujarat, India
- Annual Revenue₹32.9 Lakh
FY 2024 · +15% YoY
- Net Loss-₹25.4 Lakh
FY 2024 · -77% margin
- EBITDA-₹7.7 Lakh
FY 2024 · -23% margin
- Total Equity Funding$611.34K (USD)
in 3 rounds
- Latest Funding Round$462.35K (USD), Seed
Jul 2025
- InvestorsGujarat Venture Finance
& 2 more
Associated legal entities of Genexis Biotech
Genexis Biotech is associated with 2 registered companies on The Company Check; the primary company is Genexis Biotech Private Limited. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Genexis Biotech Private Limited CIN U24304GJ2019PTC110276 | Active | 14 Oct 2019 | Vadodara, Gujarat | ₹0.3 Cr | – | 4 | View details |
| Genexis Peptides Private Limited CIN U24299GJ2022PTC137921 | Strike Off | 30 Dec 2022 | Dashrath, Gujarat | – | – | 2 | View details |
Products & Services of Genexis Biotech
Genexis Biotech offers a comprehensive portfolio of products and services, including FBS Alternative, Growth Factors, Animal Origin-Free Proteins, and Cell Culture Media.
Sustainable serum-free solution for robust cell growth applications.
Engineered for optimal cell growth in research and production.
High-quality proteins via fermentation for ethical applications.
Supports tissue engineering and drug development processes.
Funding Insights of Genexis Biotech
Genexis Biotech has successfully raised a total of $611.34K across 3 strategic funding rounds. The most recent funding activity was a Seed round of $462.35 thousand completed in July 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $611,337
- Total Rounds 3
- Last Round Seed — $462,348
- First Round $30,056
(Dec 2023)
- Investors Count 3
All 3 funding rounds of Genexis Biotech with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2025 | $462,348 | Seed | – | Gujarat Venture Finance | |
| Oct 2024 | $118,933 | Seed | $2.74M | Benzai10 Investment Ventures | – |
| Dec 2023 | $30,056 | Seed | $2.67M | Indigram labs | – |
| Date | Valuation | Stage |
|---|---|---|
| Oct 2024 | $2.74M | •••••••• |
| Dec 2023 | $2.67M | •••••••• |
Last known valuation $2.74M (Oct 2024). 3 investors in total: 3 institutional.
Investors in Genexis Biotech
Genexis Biotech has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Gujarat Venture Finance, Indigram Labs and Benzai10 Investment Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Provider of agriculture investment services | 2020 | benzai10.co.in | Delhi, India | |
Incubation and support for startups in agritech, foodtech, clean tech, and rural healthcare sectors. | 2016 | indigramlabs.org | Delhi, India | |
Venture capital investments are made in Indian startups across multiple sectors. | 1990 | gvfl.com | Ahmedabad, India |
Investor details for Genexis Biotech
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Genexis Biotech Private Limited (Genexis Biotech)
Genexis Biotech Private Limited is the primary company behind Genexis Biotech. The boards of the 2 registered companies of Genexis Biotech currently have 4 directors; the longest-serving is Jitendra Dnyandeo Wagh, appointed in 2019. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Jitendra Dnyandeo Wagh DIN 08585626 | Director | 14 Oct 2019 | 7 yrs | Genexis Biotech Private Limited, Genexis Peptides Private Limited |
| Vipul Kumar DIN 08585627 | Director | 14 Oct 2019 | 7 yrs | Genexis Biotech Private Limited, Genexis Peptides Private Limited |
| Tamaghna Adhikari DIN 09353299 | Additional Director | 08 Mar 2025 | 1 yr 7 mo | Genexis Biotech Private Limited |
| Saurabh Rajan Nair DIN 10112215 | Nominee Director | 17 Jul 2025 | 1 yr 3 mo | Genexis Biotech Private Limited |
People of Genexis Biotech
2 people are tracked at Genexis Biotech (2 in leadership).
| Name | Role | Group |
|---|---|---|
| Co-Founder | Leadership | |
| Co-Founder | Leadership |
Complete people profiles for Genexis Biotech
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Genexis Biotech
Figures of Genexis Biotech Private Limited, the primary company behind Genexis Biotech, for FY 2024. Revenue was ₹32.9 Lakh (+15% year on year). Net loss was -₹25.4 Lakh (-77% margin). EBITDA was -₹7.7 Lakh (-23% margin). Revenue has grown at a compounded annual rate of -14% over three years.
- ₹32.9 LakhRevenue · FY 2024 · +15% YoY
- -₹25.4 LakhNet loss · -77% margin
- -₹7.7 LakhEBITDA · -23% margin
- ₹5.2 LakhPaid-up capital
- -14%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Genexis Biotech Private Limited are on its company page.
Detailed financial statements for Genexis Biotech
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Genexis Biotech
4 dated milestones of Genexis Biotech across 6 years, from founding to its latest funding, stage changes and deals.
- Founded Genexis Biotech is founded.
- Funding First funding round of $30K.
- Milestone Reaches Minicorn status.
- Funding Latest funding round, Seed, of $462K.
Competitors of Genexis Biotech
Genexis Biotech has 9 listed competitors in our database, 5 of them funded. They include Abcam, Stem Cell Technologies, Meridian Bioscience, Teknova and Sangon Biotech, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| abcam.com | 1998 | Cambridge, United Kingdom | $78.8M | 405 | Biological reagents and antibodies are developed for life science research. | |
| stemcell.com | 1993 | Vancouver, Canada | $11.92M | 129 | Developer of cell culture media and ancillary reagents for life science research | |
| meridianbioscience.com | 1976 | Ohio, United States | – | – | Molecular diagnostic device and kits | |
| teknova.com | 1996 | Hollister, United States | – | 290 | Molecular biology reagents and kits are supplied for research applications. | |
| sangon.com | 2003 | Shanghai, China | $300M | – | Research services, reagents, and kits for biotech applications are provided. | |
| caymanchem.com | 1980 | Ann Arbor, United States | – | 309 | Bioreagents and assay kits are developed, with preclinical services provided. | |
| bbisolutions.com | 1986 | Crumlin, United Kingdom | – | 301 | Kits and reagents are developed for life science research applications. | |
| biochain.com | 1994 | Hayward, United States | $7.34M | 24 | Provider of products and services for clinical diagnosis, genomics, and proteomics | |
| pl-bioscience.com | 2015 | Aachen, Germany | $13.03M | 13 | Cell culture solutions for stem cell expansion are provided. |
Detailed competitors of Genexis Biotech
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Genexis Biotech
Websites that share an audience with Genexis Biotech (genexisbiotech.com).
Websites whose visitors overlap most with Genexis Biotech. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| curiousbiotech.com | 100% | – | – | View details | |
| relaxbiotech.com | 99% | – | – | View details | |
| infinitabiotech.com | 79% | 34.6K | #933,531 | View details |
Top companies in Life Sciences Platforms & Tools
10 companies that operate in the same segment as Genexis Biotech (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Genexis Biotech
Complete news archive for Genexis Biotech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Genexis Biotech
Genexis Biotech was founded in 2019 and raised its 1st funding round 4 years after it was founded.
Genexis Biotech is headquartered in Vadodara, India. It is registered at Vadodara, Gujarat, India.
Genexis Biotech is a funded company, having raised a total of $611.34K across 3 funding rounds to date. The company's 1st funding round was a Seed of $30.06K, raised on Dec 2023.
The primary company behind Genexis Biotech, Genexis Biotech Private Limited, reported revenue of ₹32.9 Lakh for FY 2024, up 15% year on year.
Genexis Biotech was established in 2019 in Vadodara, India, within the biotechnology sector. Full-spectrum services in microbiology, molecular biology, and microbial fermentation solutions are delivered. Precision fermentation and cell culture-based technologies are employed to create alternative proteins via biological platforms. Operations focus on addressing biotechnology requirements through these methods.
Genexis Biotech's top competitors include Abcam, Meridian Bioscience and Stem Cell Technologies.
Genexis Biotech offers FBS Alternative, Growth Factors, Animal Origin-Free Proteins, and Cell Culture Media.
Genexis Biotech has 3 investors. Key investors include Gujarat Venture Finance, Indigram Labs, and Benzai10 Investment Ventures.
The valuation of Genexis Biotech is $2.74M as of Oct 2024.
Genexis Biotech is associated with 2 legal entities: Genexis Biotech Private Limited, Genexis Peptides Private Limited.
The legal entities of Genexis Biotech currently have 4 directors, including Jitendra Dnyandeo Wagh, Vipul Kumar, Tamaghna Adhikari and others.